Feminalgin
Producer: LLC NPF Materia Medika Holding Russia
Release form: Firm dosage forms. Tablets.
General characteristics. Structure:
Active ingredients: Cimicifuga racemosa (Tsimitsifuga racemase) C200, Magnesia phosphorica (Magnesium phosphate) C200, Pulsatilla pratensis (Lumbago meadow) C200
Description:
Tablets of a ploskotsilindrichesky form with a facet, white to white with creamy or color, white with a grayish shade.
Pharmacological properties:
Complex homeopathic medicine has analgeziruyushchy, spasmolytic and antiinflammatory effect. Stabilizes a psychoemotional state.
Indications to use:
Premenstrual syndrome and альгодисменорея (painful irregular periods, the increased emotional excitability, a sleep disorder, cardiovascular disturbances and neurosises)
Route of administration and doses:
Inside; on 1 tablet on reception of 4-5 times a day in 15 minutes prior to food.
Tablets hold in a mouth before full dissolution. Reception is begun in 1-2 days prior to the beginning of periods and continued during the entire period of a mestruation.
Side effects:
It is not revealed.
Interaction with other medicines:
The combination to other medicines is possible
Contraindications:
Hypersensitivity to drug components.
Storage conditions:
In the dry, protected from light place at a temperature not over 25 ºС. To store in the place, unavailable to children. Period of validity 3 years. Not to apply after a period of validity.
Issue conditions:
Without recipe
Packaging:
On 20 tablets in the blister strip packaging enclosed in a cardboard pack.